|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61F 2/14 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/557 | (2006.01) | ||
| A61K 31/565 | (2006.01) | ||
| A61K 47/34 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| A61K 31/498 | (2006.01) |
| (11) | Number of the document | 2218424 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10156875.6 |
| Date of filing the European patent application | 2007-11-09 | |
| (97) | Date of publication of the European application | 2010-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 565917 | 2006-12-01 | US |
| (72) |
Robinson, Michael R., US
Blanda, Wendy M., US
Hughes, Patrick M., US
Ruiz, Guadalupe, US
Orilla, Werhner C., US
Whitcup, Scott M., US
Lin, Joan-En, US
Welty, Devin F., US
Spada, Lon T., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Intraocular drug delivery systems |
| Intraocular drug delivery systems |